LEIDEN, Netherlands (AP) — LEIDEN, Netherlands (AP) — ProQR Therapeutics NV (PRQR) on Thursday reported a loss of $9.1 million in its fourth quarter.
On a per-share basis, the Leiden, Netherlands-based company said it had a loss of 9 cents.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 8 cents per share.
The Dutch drugmaker posted revenue of $5.5 million in the period.
For the year, the company reported a loss of $47.7 million, or 45 cents per share. Revenue was reported as $18 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRQR at https://www.zacks.com/ap/PRQR
/Alphabet%20(Google)%20Image%20by%20Markus%20Mainka%20via%20Shutterstock.jpg)
/Advanced%20Micro%20Devices%20Inc_%20office%20sign-by%20Poetra_RH%20via%20Shutterstock.jpg)
